Results per Page:
A new era of COVID-19 brings new outlooks for cellular therapy recipients
From the Liu Group, Vaccine and Infectious Disease Division
Discovering potential emerging SARS-CoV-2 variants
From the Zhao, Gilbert, Geraghty and Jerome labs, a collaboration between Public Health Sciences, Vaccine and Infectious Disease, and the Clinical Research Divisions
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
Tip Sheet: Fred Hutch experts tackle long COVID, improving outcomes for leukemia patients – and tips on staying healthy
Summaries of recent Fred Hutch research findings and other news
Researchers link mutations in coronavirus' internal machinery to higher risk of severe disease
Early COVID-19 patients were more likely to be hospitalized if virus carried genetic trait
Tip Sheet: New findings on immune response to COVID-19, new research from San Antonio Breast Cancer Symposium — and Fred Hutch expert predictions for 2022
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: Fred Hutch experts and omicron, closing gaps in indigenous health disparities, new leaders in DEI and data science — and ASH 2021
Summaries of recent Fred Hutch research findings and other news
Science Says: Fearless science
Immunotherapy, equity in colorectal cancer and the latest on the COVID-19 virus's omicron variant